Grifols Sa Stock Today

GIFLF Stock  USD 11.30  0.00  0.00%   

Performance

OK

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Grifols SA is trading at 11.30 as of the 27th of March 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 11.3. Grifols SA has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 27th of December 2024 and ending today, the 27th of March 2025. Click here to learn more.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 422.18 M outstanding shares. More on Grifols SA

Moving together with Grifols Pink Sheet

  0.61JNJ Johnson JohnsonPairCorr
  0.63RHHBF Roche Holding AGPairCorr

Moving against Grifols Pink Sheet

  0.87AXP American ExpressPairCorr
  0.86HPQ HP Inc Sell-off TrendPairCorr
  0.84BAC Bank of AmericaPairCorr
  0.78DIS Walt DisneyPairCorr
  0.75WMT WalmartPairCorr
  0.66MSFT MicrosoftPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Grifols Pink Sheet Highlights

PresidentDavid Bell
Business ConcentrationDrug Manufacturers—General, Healthcare (View all Sectors)
Grifols SA [GIFLF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Grifols SA's market, we take the total number of its shares issued and multiply it by Grifols SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Grifols SA classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 422.18 M outstanding shares. Grifols SA has accumulated about 549.09 M in cash with 596.98 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81.
Check Grifols SA Probability Of Bankruptcy
Ownership Allocation
Grifols SA has a total of 422.18 Million outstanding shares. Grifols SA secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Public38.94%Insiders30.57%Institutions30.49%100%
Check Grifols Ownership Details

Grifols SA Risk Profiles

Grifols Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Grifols SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Grifols SA Corporate Management

Nuria LapeaRisk TreasuryProfile
Maria LlanoChief OfficerProfile
M TubauCo AffairsProfile
Steven JDEx ChairmanProfile
Montserrat LlamasChief OfficerProfile
Vctor DeuCoCEO DirectorProfile

Other Information on Investing in Grifols Pink Sheet

Grifols SA financial ratios help investors to determine whether Grifols Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grifols with respect to the benefits of owning Grifols SA security.